v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 32,429 $ 30,321
Accounts receivable 3,399 3,563
Contract assets and unbilled receivables (Note 10) 1,178 2,209
Prepaids and other current assets 1,433 515
Short-term investments 0 2
Total current assets 38,439 36,610
Property and equipment, net 226 252
Total assets 38,665 36,862
Current liabilities:    
Accounts payable 1,465 3,148
Accrued expenses and other liabilities 6,927 8,147
Warrant liabilities 11,800 0
Total current liabilities 20,192 11,295
Long term funding agreement, related party 1,000 0
Total liabilities 21,192 11,295
Commitments and contingencies (Note 3 and Note 9)
Series A preferred stock, par value $0.0001; 14,146 shares were designated as of June 30, 2025 and December 31, 2024; zero and 14,145.374 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively. 0 18,843
Stockholders' equity:    
Preferred stock, par value $0.0001; 9,985,854 shares authorized as of June 30, 2025 and December 31, 2024; no shares issued and outstanding at June 30, 2025 and December 31, 2024. 0 0
Common stock, par value $0.0001; 125,000,000 shares authorized as of June 30, 2025 and December 31, 2024; 59,908,055 and 31,574,657 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively. 6 3
Additional paid-in capital 172,079 145,719
Accumulated deficit (154,612) (138,998)
Total stockholders' equity 17,473 6,724
Total liabilities, series A preferred stock and stockholders' equity $ 38,665 $ 36,862

Source